The Relationship Between Atrial Fibrillation and Frailty in Community-Dwelling Elderly
NCT ID: NCT03420326
Last Updated: 2019-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
256 participants
OBSERVATIONAL
2018-01-26
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
NCT04518423
Application of Frailty Prevention Care Management Program of Community Elderly Adults
NCT05883423
The Effect of Frailty and Other Geriatric Syndromes on the Prognosis of Elderly Patients With Acute Coronary Syndrome
NCT04580706
Exploring the Relationship Between ICOPE Framework and Frailty Among Community-dwelling Elderly Individuals
NCT06140212
The Effects of Intelligent Intervention Programs on Hospitalized Elderly People With Frailty.
NCT06875024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atria fibrillation (AF) group
1. Detection of AF during 30 seconds ECG assessment
2. Once diagnosed with atrial fibrillation before
3. Undergo the frailty status assessment
Frailty status assessment
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status
Non-AF group
1. No detection of AF during 30 seconds ECG assessment
2. Undergo the frailty status assessment
Frailty status assessment
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Frailty status assessment
The Edmonton frail scale and Frailty criteria by Dr. Fried would be used to assess participants frailty status
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1. Cardiovascular diseases: myocardial infarction, peripheral vascular diseases, aortic plaque
2. Cerebrovascular disease: stroke, transient ischemic attack, emboli
3. Heart failure
4. Participants who cannot finish the trial
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meng-Yueh Chien
Role: STUDY_CHAIR
College of medicine, National Taiwan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ming-Ting Yang
Taipei, Zhongzheng District, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201711083RIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.